Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity

BACKGROUND: Recombinant allergens are under investigation for replacing allergen extracts in immunotherapy. Site-directed mutagenesis has been suggested as a strategy to develop hypoallergenic molecules that will reduce the risk of side effects. For decades, chemically modified allergen extracts hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Versteeg, Serge A., Bulder, Ingrid, Himly, Martin, van Capel, Toni M., van den Hout, R., Koppelman, Stef J., de Jong, Esther C., Ferreira, Fatima, van Ree, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488918/
https://www.ncbi.nlm.nih.gov/pubmed/23268458
http://dx.doi.org/10.1097/WOX.0b013e3182228a39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488918/
https://www.ncbi.nlm.nih.gov/pubmed/23268458
http://dx.doi.org/10.1097/WOX.0b013e3182228a39

Ejemplares similares